GeneDx Holdings Corp. financials

WGS CIK 0001818331

Source: EDGAR filings · Built 2026-06-02T04:23:03Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 11.81M -36.72M -189.00M -329.60M -203.56M -121.23M
EBITDA -3.48M -15.31M -160.90M -617.65M -424.34M -230.26M
Working Capital 159.38M 143.15M 123.52M 68.33M 382.26M 100.67M
Net Debt 9.99M 34.80M 23.15M -46.80M -367.77M -87.39M
Gross Margin 69.74% 63.64% 44.43% -11.40% -7.82% 2.25%
Operating Margin -3.06% -7.60% -89.15% -284.48% -210.25% -134.95%
Net Margin -4.92% -17.12% -86.77% -233.91% -115.64% -134.58%
Return on Equity (ROE) -6.82% -21.32% -77.08% -216.39% -63.23% 73.12%
Return on Assets (ROA) -4.01% -12.47% -41.97% -111.82% -44.29% -95.91%
Current Ratio 2.46× 3.61× 3.10× 1.47× 4.77× 2.37×
Debt-to-Equity 0.37× 0.49× 0.54× 0.30× 0.08× -0.06×
Effective Tax Rate 0.55% 0.65% 0.52% 8.20% 0.00% 0.00%
Cash Conversion Ratio -1.58× 0.55× 1.02× 0.58× 0.78× 0.39×
Accruals Ratio -0.10× -0.06× 0.01× -0.47× -0.10× -0.59×
SBC % of Revenue 7.52% 2.99% -0.16% 17.89% 103.41% 67.05%
CapEx Coverage 1.55× -3.47× -20.36× -30.55× -14.51× -3.31×
Free Cash Flow Per Share $0.41 $-1.37 $-7.77 $-32.20 $-1.88 $-23627.36

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/FCF 315.37×
FCF Yield 0.32%
P/S 8.90× 7.05× 0.35× 0.01× 5.10× 0.00×
P/B 12.34× 8.78× 0.31× 0.01× 2.79×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 427.54M 305.45M 202.57M 234.69M 212.19M 179.32M
Cost of Goods and Services Sold 129.37M 111.05M 112.56M 261.44M 228.80M 175.30M
Gross Profit 298.17M 194.40M 90.01M -26.75M -16.60M 4.03M
Research and Development Expense 72.03M 45.72M 58.27M 86.20M 105.16M 72.70M
Operating Income (Loss) -13.08M -23.21M -180.60M -667.65M -446.15M -241.99M
Income Tax Expense (Benefit) -116.00K -343.00K -926.00K -49.05M 0 0
Net Income (Loss) Attributable to Parent -21.02M -52.29M -175.77M -548.98M -245.39M -241.34M
Earnings Per Share, Basic $-0.73 $-1.94 $-7.23 $-53.63 $-2.27 $-47036.00
Weighted Average Number of Shares Outstanding, Basic 28.64M 26.89M 24.31M 10.24M 108.08M 5,131
Earnings Per Share, Diluted $-0.73 $-1.94 $-7.23 $-53.63 $-2.27 $-47036.00
Weighted Average Number of Shares Outstanding, Diluted 28.64M 26.89M 24.31M 10.24M 108.08M 5,131

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 105.00M 85.21M 99.68M 123.93M 400.57M 108.13M
Assets, Current 268.29M 197.97M 182.34M 212.62M 483.54M 174.11M
Assets 523.71M 419.38M 418.76M 490.94M 554.09M 251.64M
Long-term Debt 54.54M 55.75M 56.25M 11.00M 11.00M
Liabilities, Current 108.91M 54.82M 58.82M 144.30M 101.28M 73.44M
Long-term Debt, Excluding Current Maturities 48.18M 51.91M 52.69M 6.25M 11.00M 18.97M
Liabilities 215.53M 174.13M 190.74M 237.24M 165.99M 247.25M
Stockholders' Equity Attributable to Parent 308.18M 245.25M 228.02M 253.71M 388.10M -330.05M
Common Stock, Shares, Outstanding 29.25M 28.02M 25.98M 11.77M 242.65M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 33.28M -28.50M -180.15M -319.15M -190.43M -93.13M
Payments to Acquire Property, Plant, and Equipment 19.02M 5.49M 5.25M 7.16M 9.40M 24.09M
Net Cash Provided by (Used in) Investing Activities -61.52M -30.13M -43.73M -141.33M -20.79M -31.97M
Net Cash Provided by (Used in) Financing Activities 48.02M 44.16M 186.24M 197.31M 493.73M 129.06M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (WGS CIK 0001818331), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ALMU

AELUMA, INC.

GAIA

GAIA, INC

PLRX

PLIANT THERAPEUTICS, INC.